Michael Paskind
- Immunology top 0.5%
- Immunodeficiency and Autoimmune Disorders 5
- Hematology top 1%
- Chronic Myeloid Leukemia Treatments 6
- Virology top 2%
- HIV Research and Treatment 4
- Molecular Biology top 2%
- Glycosylation and Glycoproteins Research 5
- Phosphodiesterase function and regulation 3
- RNA Research and Splicing 3
-
- Monoclonal and Polyclonal Antibodies Research 8
-
- HIV/AIDS drug development and treatment 3
- Co-authors
- David BaltimoreStephen DesiderioGeorge D. YancopoulosFrederick W. AltDaniel E. TraceyRobert KamenSubhashis BanerjeeWinnie W. Wong
- Cited by
- ImmunologyHematologyVirology
- Partner nations
- United StatesGermanyAustralia
In The Last Decade
Michael Paskind
33 papers receiving 6.0k citations
Hit Papers
Peers
Comparison fields: 5 of 114
- Immunology 2.9k
- Hematology 773
- Virology 284
- Molecular Biology 3.7k
- Radiology, Nuclear Medicine and Imaging 1.1k
Countries citing papers authored by Michael Paskind
This map shows the geographic impact of Michael Paskind's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Paskind with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Paskind more than expected).
Fields of papers citing papers by Michael Paskind
This network shows the impact of papers produced by Michael Paskind. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Paskind. The network helps show where Michael Paskind may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Michael Paskind, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 7 | |
| 2 | 1999 | 21 | |
| 3 | 1998 | 30 | |
| 4 | 1997 | 221 | |
| 5 | Caspase-1 processes IFN-γ-inducing factor and regulates LPS-induced IFN- γ productionbreakdown → | 1997 | 1037 |
| 6 | 1996 | 70 | |
| 7 | 1996 | 2 | |
| 8 | Mice deficient in IL-1β-converting enzyme are defective in production of mature IL-1β and resistant to endotoxic shockbreakdown → | 1995 | 1225 |
| 9 | 1995 | 238 | |
| 10 | 1993 | 197 | |
| 11 | Mutation of a phenylalanine conserved in SH3-containing tyrosine kinases activates the transforming ability of c-Abl. | 1993 | 33 |
| 12 | 1987 | 32 | |
| 13 | 1987 | 148 | |
| 14 | 1984 | 447 | |
| 15 | 1983 | 32 | |
| 16 | 1981 | 11 | |
| 17 | 1980 | 228 | |
| 18 | 1975 | 70 | |
| 19 | 1974 | 47 | |
| 20 | 1974 | 144 |
About Michael Paskind
Michael Paskind is a scholar working on Hematology, Virology and Immunology, having authored 33 papers that have together received 6.4k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (8 papers), Chronic Myeloid Leukemia Treatments (6 papers), Glycosylation and Glycoproteins Research (5 papers), Immunodeficiency and Autoimmune Disorders (5 papers), HIV Research and Treatment (4 papers), HIV/AIDS drug development and treatment (3 papers), Phosphodiesterase function and regulation (3 papers) and RNA Research and Splicing (3 papers). The work is most often cited by research in Immunology (2.9k citations), Hematology (773 citations) and Virology (284 citations). Michael Paskind has collaborated with scholars based in United States, Germany and Australia. Frequent co-authors include David Baltimore, Stephen Desiderio, George D. Yancopoulos, Frederick W. Alt, Daniel E. Tracey, Robert Kamen, Subhashis Banerjee, Winnie W. Wong, Alfred L.M. Bothwell and Thereza Imanishi‐Kari. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences, Cell, Journal of Virology and European Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.